Researchers at the Indian Institute of Science (IISc) Bengaluru have developed a water-filter membrane with co...Read more
A start-up born at the IIT-Madras Incubation Cell has bagged a million dollar order from a Singapore-based com...Read more
Pharmaceutical industry continues to grow The Indian pharma industry has been growing at a compounded annual ...Read more
Lupin Limited has recently announced unanimous appointment of Manju Deshbandhu Gupta as Chairman. She has bee...Read more
Shortage In Europe of Oncology Drugs... An opportunity for Indian Pharma?
Indian drug companies are facing strong headwinds due to prompt regulatory action of United States Food and Drug Administration (USFDA), likely imposition of Border Adjustment Tax (BAT) and delay in new drug approvals. Probably, it is the best time for Indian pharma companies to explore opportunities and business in the European market.